GE HealthCare Enters Photon-Counting CT Market with FDA Clearance

GE HealthCare has secured 510(k) clearance from the U.S. Food and Drug Administration for its Photonova Spectra system, marking its entry into the photon-counting CT segment. The approval positions the company to compete with Siemens Healthineers, whose Naeotom Alpha was the first such system cleared in the U.S.

Photon-counting CT technology improves imaging by directly measuring X-ray photons, eliminating the traditional light-conversion step and preserving more diagnostic data. GE’s system uses a “deep silicon” detector, designed to enhance contrast and enable clearer differentiation between materials such as calcium, iodine, and fat.

Analysts highlight its potential across multiple applications, including cardiac and neurological imaging, along with easier installation requirements that may speed adoption.

With orders expected to build through 2026, the technology could become a significant growth driver, with broader commercial impact anticipated in the following year.

28-04-2026